These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 10875033)

  • 41. Combined effects of nitrates on the coronary and peripheral circulation in exercise-induced ischemia.
    De Coster PM; Chierchia S; Davies GJ; Hackett D; Fragasso G; Maseri A
    Circulation; 1990 Jun; 81(6):1881-6. PubMed ID: 2344681
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Anti-ischaemic response to sublingual nitroglycerin during oral administration of isosorbide dinitrate in patients with stable angina pectoris: when does cross-tolerance occur?
    Kośmicki MA; Szwed H; Sadowski Z
    Cardiovasc Drugs Ther; 2004 Jan; 18(1):47-55. PubMed ID: 15115903
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Concentration-time profile of isosorbide dinitrate and its metabolites in plasma following percutaneous resorption of a transdermal therapeutic system].
    Menke G; Schnellhammer R; Rietbrock N
    Arzneimittelforschung; 1987 Nov; 37(11):1301-3. PubMed ID: 3440041
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Controlled, eight-hour haemodynamic study of a sustained-release formulation of isosorbide dinitrate in moderate left ventricular failure.
    Dubourg O; Gueret P; Ferrier A; Farcot JC; Terdjman M; Rigaud M; Beaumont D; Bardet J; Bourdarias JP
    Eur J Clin Pharmacol; 1984; 27(3):259-63. PubMed ID: 6510452
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Equal anti-ischemic properties of isosorbide dinitrate plus verapamil and isosorbide dinitrate plus propranolol. A randomized, double-blind and crossover study.
    Silber S; Vogler A; Theisen K
    Z Kardiol; 1986; 75 Suppl 3():100-5. PubMed ID: 3541414
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Long-term therapy of stress angina pectoris by a single daily administration of 120 mg isosorbide dinitrate in retard form. Comparison of monotherapy and combination therapy with atenolol and nifedipine].
    Blasini R; Brügmann U; Reiniger G; Rudolph W
    Herz; 1985 Jun; 10(3):163-71. PubMed ID: 3926613
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Haemodynamics and plasma concentrations following sublingual GTN and intravenous, or inhaled, isosorbide dinitrate.
    Culling W; Singh H; Bashir A; Griffiths BE; Dalal JJ; Sheridan DJ
    Br J Clin Pharmacol; 1984 Feb; 17(2):125-31. PubMed ID: 6422972
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Optimal nitrate therapy with a once-daily sustained-release formulation of isosorbide mononitrate.
    Waller DG
    J Cardiovasc Pharmacol; 1999 Aug; 34 Suppl 2():S21-7; discussion S29-31. PubMed ID: 10499557
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Isosorbide Dinitrate, With or Without Hydralazine, Does Not Reduce Wave Reflections, Left Ventricular Hypertrophy, or Myocardial Fibrosis in Patients With Heart Failure With Preserved Ejection Fraction.
    Zamani P; Akers S; Soto-Calderon H; Beraun M; Koppula MR; Varakantam S; Rawat D; Shiva-Kumar P; Haines PG; Chittams J; Townsend RR; Witschey WR; Segers P; Chirinos JA
    J Am Heart Assoc; 2017 Feb; 6(2):. PubMed ID: 28219917
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pre- and afterload reduction in chronic mitral regurgitation: a double-blind randomized placebo-controlled trial of the acute and 2 weeks' effect of nifedipine or isosorbide dinitrate treatment on left ventricular function and the severity of mitral regurgitation.
    Kelbaek H; Aldershvile J; Skagen K; Hildebrandt P; Nielsen SL
    Br J Clin Pharmacol; 1996 Jun; 41(6):493-7. PubMed ID: 8799512
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparative pharmacokinetics of isosorbide nitrates after repeated doses of sustained release isosorbide dinitrate.
    Laufen H; Leitold M; Wildfeuer A
    Arzneimittelforschung; 1988 Sep; 38(9):1336-41. PubMed ID: 3223973
    [TBL] [Abstract][Full Text] [Related]  

  • 52. What intervals in oral therapy of isosorbide dinitrate in various doses are sufficient to prevent nitrate tolerance?
    Kośmicki M; Sadowski Z; Szwed H; Kowalik I
    Med Sci Monit; 2000; 6(4):763-8. PubMed ID: 11208406
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hemodynamic and humoral effects at rest and after head-up tilt tests during 24-hour infusion of a new nitrate ester, ITF 296, compared with ISDN and placebo in healthy volunteers: a double-blind, randomized, within-subject study.
    Sardina M; Warrington SJ; Boyce M; Johnston A; Bianchini C
    J Cardiovasc Pharmacol; 1995; 26 Suppl 4():S80-90. PubMed ID: 8839231
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Oral absorption and disposition of isosorbide dinitrate and isosorbide mononitrates in man.
    Laufen H; Aumann M; Leitold M
    Arzneimittelforschung; 1983; 33(7):980-4. PubMed ID: 6684933
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Induction and circumvention of nitrate tolerance applying different dosage intervals.
    Silber S; Vogler AC; Krause KH; Vogel M; Theisen K
    Am J Med; 1987 Nov; 83(5):860-70. PubMed ID: 3674093
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Dose-effect relationship of isosorbide dinitrate in the treatment of angina pectoris (author's transl)].
    Schneider W; Stahl B; Kaltenbach M; Bussmann WD
    Dtsch Med Wochenschr; 1982 May; 107(20):771-6. PubMed ID: 7075499
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [8-hour hemodynamic study of 2 sustained-release nitrate derivatives. Comparative double-blind study against placebo].
    Dubourg O; Guéret P; Ferrier A; Léger P; Farcot JC; Rigaud M; Beaumont D; Bardet J; Bourdarias JP
    Arch Mal Coeur Vaiss; 1983 Feb; 76(2):211-9. PubMed ID: 6407429
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Nitrovasodilators ITF 296 and isosorbide dinitrate exert antiischemic activity by dilating coronary penetrating arteries.
    Duncker DJ; Mizrahi J; Bache RJ
    J Cardiovasc Pharmacol; 1995 May; 25(5):823-32. PubMed ID: 7630161
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Anti-angina effectiveness of isosorbide dinitrate in an acute trial and following continuous 4-week therapy with 40 mg 6 times a day].
    Schneider W; Wietschoreck A; Bussmann WD; Kaltenbach M
    Klin Wochenschr; 1985 May; 63(10):460-7. PubMed ID: 3925217
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Potentiation of isosorbide dinitrate effects with N-acetylcysteine in patients with chronic heart failure.
    Mehra A; Shotan A; Ostrzega E; Hsueh W; Vasquez-Johnson J; Elkayam U
    Circulation; 1994 Jun; 89(6):2595-600. PubMed ID: 8205670
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.